|
(V809) |
Inhibition of NHE3-mediated sodium absorption in the gut reduced atrial fibrillation susceptibility in obese spontaneously hypertensive rats |
| |
|
D. Linz, M. Hohl, D. Lau, P. Sanders, M. Böhm (Adelaide, AU; Homburg/Saar) |
|
|
Diskussion |
|
(V810) |
Ventricular dysfunction and fibrosis precedes atrial fibrillation in JDP2 overexpression mice |
| |
|
G. Euler, J. Bornbaum, N. Brockmann, J. Heger, P. Ferdinandy, R. Schulz (Gießen; Budapest, HU) |
|
|
Diskussion |
|
(V811) |
Atrial arrhythmopathy-associated remodeling of two-pore-domain potassium (K2P) channels in murine disease models – focus on TASK-1 |
| |
|
F. Wiedmann, J. S. Schulte, B. F. Gomes, A. Ratte, F. U. Müller, N. Voigt, M. P. Zafeiriou, M. Karck, G. Szabó, U. Tochtermann, A. Ruhparwar, H. A. Katus, D. Thomas, C. Schmidt (Heidelberg, Münster, Göttingen) |
|
|
Diskussion |
|
(V812) |
Cellular basis of atrial hypocontractility in patients with persistent atrial fibrillation |
| |
|
F. Fakuade, M.-L. Chang Liao, C. E. Molina, I. Kutschka, N. Voigt (Göttingen) |
|
|
Diskussion |
|
(V813) |
Late INa is enhanced in patients with sleep-disordered breathing |
| |
|
S. Lebek, K. Pichler, J. Mustroph, M. Tafelmeier, L. Rupprecht, D. Camboni, C. Schmid, Y. Zausig, L. S. Maier, M. Arzt, S. Wagner, für die Studiengruppe: CONSIDER-AF (Regensburg) |
|
|
Diskussion |
|
(V814) |
Application of intermittent negative upper airway pressure as a novel rat model for obstructive sleep apnea and atrial fibrillation |
| |
|
M. Hohl, B. Linz, A. Nickel, C. Maack, U. Schotten, P. Sanders, M. Böhm, D. Linz (Homburg/Saar, Würzburg; Maastricht, NL; Adelaide, AU) |
|
|
Diskussion |